Zanganeh Mahkam

Summit Therapeutics Inc. · Co-Chief Executive Officer

Zanganeh Mahkam is listed in public filings as director, 10 percent owner, officer: Co-Chief Executive Officer. This Zanganeh Mahkam insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Summit Therapeutics Inc. (SMMT), and Pulse Biosciences, Inc. (PLSE). Investors use Zanganeh Mahkam's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Summit Therapeutics Inc.SMMT	$377M25.8M shares	BuyJun 4, 2026	$1.5M100k shares	$14.60	--

Insider Trades History

Company	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Summit Therapeutics Inc.SMMT	$197k11.2k shares	Grant / ExerciseJan 2, 2026	$196.8K11.2k shares	$17.52	--
Summit Therapeutics Inc.SMMT	$11B570.1M shares	Grant / ExerciseOct 21, 2025	$262.0M14M shares	$18.74	--
Summit Therapeutics Inc.SMMT	$482M25.7M shares	Grant / ExerciseOct 21, 2025	$5.0M266.8k shares	$18.74	--
Summit Therapeutics Inc.SMMT	$1.4M76.7k shares	BuyOct 21, 2025	$500.0K26.7k shares	$18.74	--
Summit Therapeutics Inc.SMMT	$10B556.1M shares	BuySep 11, 2025	$90.3K5k shares	$18.07	--
Summit Therapeutics Inc.SMMT	$9.8B556.1M shares	BuySep 10, 2025	$5.9M333.4k shares	$17.68	--
Pulse Biosciences, Inc.PLSE	$485k30k shares	Grant / ExerciseAug 15, 2025	$484.8K30k shares	$16.16	--
Pulse Biosciences, Inc.PLSE	$390k24.1k shares	Grant / ExerciseAug 15, 2025	$390.0K24.1k shares	$16.16	--
Summit Therapeutics Inc.SMMT	$074.5k shares	Grant / ExerciseMay 30, 2025	$196.8K74.5k shares	$2.64	--
Summit Therapeutics Inc.SMMT	$16M9.6M shares	Grant / ExerciseApr 29, 2025	$16.1M9.6M shares	$1.68	--
Summit Therapeutics Inc.SMMT	$1.1M1M shares	Grant / ExerciseApr 29, 2025	$1.1M1M shares	$1.06	--
Summit Therapeutics Inc.SMMT	$516k400k shares	Grant / ExerciseApr 29, 2025	$516.0K400k shares	$1.29	--
Summit Therapeutics Inc.SMMT	$04M shares	OtherApr 8, 2025	$6.3M4M shares	$1.58	--
Pulse Biosciences, Inc.PLSE	$030.1k shares	OtherFeb 3, 2025	$331.3K30.1k shares	$11.00	--
Pulse Biosciences, Inc.PLSE	$7.6M695.3k shares	OtherJan 24, 2025	$331.3K30.1k shares	$11.00	--
Summit Therapeutics Inc.SMMT	$197k10.7k shares	Grant / ExerciseJan 2, 2025	$196.8K10.7k shares	$18.35	--
Summit Therapeutics Inc.SMMT	$0315.7k shares	OtherOct 3, 2024	$498.8K315.7k shares	$1.58	--
Summit Therapeutics Inc.SMMT	$567M25M shares	Grant / ExerciseSep 11, 2024	$1000.0K44.1k shares	$22.70	--
Summit Therapeutics Inc.SMMT	$4.0M2.4M shares	Grant / ExerciseAug 23, 2024	$4.0M2.4M shares	$1.68	--
Summit Therapeutics Inc.SMMT	$276k260k shares	Grant / ExerciseAug 23, 2024	$275.6K260k shares	$1.06	--
Summit Therapeutics Inc.SMMT	$129k100k shares	Grant / ExerciseAug 23, 2024	$129.0K100k shares	$1.29	--
Pulse Biosciences, Inc.PLSE	$3.1M200k shares	Grant / ExerciseAug 9, 2024	$3.1M200k shares	$15.65	--
Pulse Biosciences, Inc.PLSE	$6.7M665.2k shares	OtherJul 3, 2024	$602.4K60.2k shares	$10.00	--
Pulse Biosciences, Inc.PLSE	$331k30.1k shares	BuyJul 3, 2024	$331.3K30.1k shares	$11.00	--